Gonorrhea Treatment Market size is projected to witness around 3.6% CAGR during the forecast period i.e., between 2024-2036.
The growth of the gonorrhea treatment market can be attributed to the growing prevalence of gonorrhea, increasing incidents of unprotected sex, and rise in implementation of national screening programs. In 2018, more than 1.5 million gonococcal infections occurred in the United States. Among these, more than half of the people were aged between 15-24 years. Along with these, huge investments in the R&D activities to develop effective treatment options is also expected to drive market growth in the near future. Furthermore, improvement in healthcare infrastructure in developed nations and expanding advent of new diagnostic tests are evaluated to offer lucrative opportunities to the market in the coming years.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
3.6% |
|
Regional Scope |
|
The market is segmented by treatment into monotherapy and dual therapy, out of which, the dual therapy segment is anticipated to hold the largest share in the gonorrhea treatment market on account of increasing preference of this therapy over monotherapy for treating symptomatic and asymptomatic gonorrhea, and the rising adoption of the treatment regime globally. Moreover, as dual therapy with azithromycin and ceftriaxone is considered to be as the first-line regimen for treating gonorrhea, the segment is anticipated to also witness noteworthy growth in the forecast period. Additionally, on the basis of distribution channel, the segment for hospital pharmacies is evaluated to occupy the largest market share during the forecast period. This can be credited to the ease to receive prescribed medicines from the hospital facility itself.
Our in-depth analysis of the global market includes the following segments
|
By Treatment |
|
|
By Infection Type |
|
|
By Distribution Channel
|
|
North America Market Statistics
On the basis of geographical analysis, the gonorrhea treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America industry is set to dominate majority revenue share by 2036, on the back of easy availability of advanced technology and high standards of healthcare infrastructure in the region. In addition, increasing awareness about the disease and promising reimbursement policies are also expected to drive market growth in the region.
APAC Market Analysis
However, the gonorrhea treatment market in Asia Pacific is assessed to witness the highest growth during the forecast period ascribing to the rising prevalence of the disease, rapid change in lifestyles and growing availability of cure for sexually transmitted diseases in the region. In India, more than 5% of the population is affected with a STD. On an average, every year 8-25% men suffer from gonorrhea.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?